Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Head and/or Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04946968
What this trial is testing

Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers

Who this might be right for
Advanced Solid TumoursNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma
National Cancer Centre, Singapore 24
Testing effectiveness (Phase 2)Ended earlyNCT00002735
What this trial is testing

SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 68
Early research (Phase 1)Study completedNCT00779389
What this trial is testing

Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family

Who this might be right for
Head and Neck CancerNon Small Cell Lung Cancer
University of Pittsburgh 58
Testing effectiveness (Phase 2)Study completedNCT00076310
What this trial is testing

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 50
Not applicableStudy completedNCT01179074
What this trial is testing

Role of Radiotherapy Following Oesophageal Stenting in Cancer

Who this might be right for
Oesophageal Cancer
All India Institute of Medical Sciences 84
Testing effectiveness (Phase 2)Study completedNCT00281736
What this trial is testing

Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

Who this might be right for
Esophageal CancerPrecancerous Condition
Roswell Park Cancer Institute 60
Not applicableStudy completedNCT07199712
What this trial is testing

Ozone Therapy for Oral Mucositis in Patients Receiving Head and Neck Cancer Radio- and Chemotherapy

Who this might be right for
Oral MucositisOral StomatitisHead and Neck Cancer Squamous Cell Carcinoma+2 more
University of Pavia 58
Not applicableStudy completedNCT00040911
What this trial is testing

Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma

Who this might be right for
Brain TumorsCentral Nervous System TumorsChildhood Germ Cell Tumor+8 more
Children's Oncology Group 17
Early research (Phase 1)Ended earlyNCT04272034
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more
Incyte Corporation 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT07711470
What this trial is testing

Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 140
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Not applicableLooking for participantsNCT05047094
What this trial is testing

Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaSkin CancerMetastatic Head-and-neck Squamous-cell Carcinoma
Alpha Tau Medical LTD. 48
Testing effectiveness (Phase 2)Looking for participantsNCT04198766
What this trial is testing

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+5 more
Inhibrx Biosciences, Inc 340
Not applicableStudy completedNCT01624220
What this trial is testing

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Who this might be right for
Spinal Tumor
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT04223024
What this trial is testing

Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 246
Testing effectiveness (Phase 2)Looking for participantsNCT05156060
What this trial is testing

Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerLocally Advanced Head and Neck Carcinoma
Natalie Lockney 64
Testing effectiveness (Phase 2)Study completedNCT00358930
What this trial is testing

ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 60
Testing effectiveness (Phase 2)Looking for participantsNCT06657690
What this trial is testing

Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 56
Large-scale testing (Phase 3)Study completedNCT05523323
What this trial is testing

Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010/LEAP-010)-China Extension

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 112
Early research (Phase 1)Ended earlyNCT00023790
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

Who this might be right for
Breast CancerHead and Neck CancerLymphoma+3 more
Case Comprehensive Cancer Center 3
Next Page